BA/BE studies of Biologics and Biosimilars

 A biosimilar is a biologic therapeutic item which is duplicate of a unique item that is produced by an alternate organization. Biosimilars are authoritatively sanction forms of unique "discoverer" items, and can be produced when the first item's patent terminates. Reference to the pioneer item is a fundamental part of the approbation.

 

  • Bioanalytical Approaches
  • Cancer therapeutics
  • Cardiovascular therapeutics
  • Diabetes therapeutics
  • Adverse drug reactions with pharmaceutical products

Related Conference of BA/BE studies of Biologics and Biosimilars

January 19-20, 2026

17th International Conference on Biofuels and Bioenergy

Barcelona, Spain
May 04-05, 2026

7th International Conference on Drug Chemistry

Paris, France
July 23-24, 2026

22nd World Congress on Structural Biology

Aix-en-Provence, France
September 03-04, 2026

16th World Glycobiology Congress

Aix-en-Provence, France
September 21-22, 2026

24th International Conference on Structural Biology

Barcelona, Spain

BA/BE studies of Biologics and Biosimilars Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in